Vaccine stocks now may follow last year gloves stock rally trend. All people now MCO stay at home to buy same like last year. Today is only the first day whole country stay at home. Game still long long way to go...
I think this counter has more room to go up. It follow Pharma which is now double Dpharma price. Dpharma has a lot to catch up but wait till the big players shift their focus from Pharma to Dpharma. Good luck to all of us !!
F.kk u! who are you also we don't know! want to give advice? ________________________________________________ 433tikitaka My advice to you guys, enter now. This counter will blow up, 2021 is vaccination year. All the best 01/06/2021 10:53 AM
How's that ever going to happen when Sputnik cannot be approved? And even so, only 3.5 million doses to be handled. Would that brings hundreds of millions profits changes to their 2021?
"On the Sputnik V vaccine, Health Minister Datuk Seri Dr Adham Baba will sign an agreement with Duopharma Biotech Bhd and its evaluation will be done by NPRA.
Are you not aware that the Sputnik Agreement was signed months ago? And did you not know that Sputnik has EUA in more than 64 other countries in the world?
NPRA submission was done months ago, but Malaysian specialist are far superior than others the world over.
Big roadblock by few person. These are not desperate sellers. Means they purposely set at 3.3 and 3.31 to shake off others to sell them below RM 3.3. Once accumulate enough tickets they wait for opportunity to push up again. Personal view.
OTHERS 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; A
OTHERS 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; AND 2. SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND ("RDIF") AND DMSB, FOR THE DISTRIBUTION OF THE VACCINE IN MALAYSIA. DUOPHARMA BIOTECH BERHAD
Type Announcement Subject OTHERS Description 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; AND 2. SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND ("RDIF") AND DMSB, FOR THE DISTRIBUTION OF THE VACCINE IN MALAYSIA. We refer to the announcements made on 26 January 2021, 25 February 2021, 11 March 2021, 1 April 2021, 9 April 2021 and 30 April 2021 in relation to the RDIF Term Sheet and the Government Term Sheet (“Announcements”). For consistency purposes, the abbreviations used in this announcement are the same as those previously defined in the Announcements unless otherwise defined herein.
The Board of Directors (the “Board”) of Duopharma Biotech Berhad (“Duopharma Biotech” or the “Company”) wishes to announce the following:
1. in furtherance of the RDIF Term Sheet, RDIF had nominated and authorised a subsidiary of RDIF (the “Seller”), to enter into the supply agreement with DMSB to perform the obligations for the supply of the Vaccine to DMSB as envisaged under the RDIF Term Sheet;
2. pursuant to the Government Term Sheet, DMSB had on 31 May 2021 received from the Government for DMSB’s execution a supply agreement dated 25 May 2021 that had been executed by the Government for the supply by DMSB to the Government of the finished form of the Vaccine upon the terms and conditions therein contained (the “Government Supply Agreement”), and that DMSB has executed the Government Supply Agreement; and
3. DMSB has also executed a supply agreement dated 12 May 2021 with the Seller for the supply to DMSB of the finished form of the Vaccine in the Territory upon the terms and conditions therein contained.
Please refer to the attachment for details of the announcement.
I don’t get market makers sometimes. Why suppress the price at 3.30 w a large sell q. Market makers shld know that if the price rises higher the value of their holdings is worth more.
These market makers manipulate the q to make it seem that there are more sellers. And scare off weak retailers into selling. When their own bids are fulfilled, they release the sell q and let the price run up. And then dispose.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DreamHunter
10,922 posts
Posted by DreamHunter > 2021-05-31 23:56 | Report Abuse
ha ha ha